Calyx is a trusted name in medical imaging, with over 25 years of experience supporting more than 2,600 clinical trials. Although we are widely known for our oncology expertise, we also have extensive experience in neuroimaging, including neuro-oncologic, neuro-degenerative, and neuro-psychiatric indications.
We have provided essential imaging services for nearly 200 clinical trials with CNS imaging, many of which have resulted in approved medical treatments.
These are the central nervous system (CNS) studies supported:
- CNS/Neurology Studies | 176
- Multiple sclerosis studies | 37
- Stroke Studies | 37
- Neuro-oncology | 33
- Alzheimer’s disease studies | 21
- Parkinson’s studies | 7
- Seizure studies | 5
- Neuropathy studies | 3
- Acromegaly/Pituitary Adenoma | 3
- Sickle Cell studies | 3
- Dementia studies | 2
- Brain Injury studies | 2
- Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) | 2
- Spinal Cord Injury studies | 1
- Migraines | 1
- Schizophrenia | 1
- Adrenoleukodystrophy (ALD) | 1
- Multiple System atrophy (MSA) | 1
With industry-leading readers, a proven approach to clinical trial imaging, and experience from having supported many approved CNS disorder treatments, Calyx Medical Imaging gives you confidence that your compound will pass regulatory scrutiny. Or if it’s going to fail, to fail fast.
By working with Calyx, you have access to some of the industry’s most renowned imaging experts. Our in-house medical imaging experts, including MDs, PhDs, imaging technologists, imaging physicists, and a dedicated Exploratory Imaging group are equipped and well-positioned to help you gain the information needed from new and novel imaging methods.
Chief Medical Officer
Stephen M. Bravo, MD
Vice President, Medical and Scientific Services
Rohit Sood, MD, PhD
Director, Scientific & Medical Services
Manuela Lesch, RT
Calyx’s comprehensive suite of neuro-imaging services includes:
Design of image acquisition protocols
Preparation of Independent Review Charters (IRC)
Site standardization, training, and management
Reviewer selection, training, and monitoring)
Independent review and eligibility/safety review
Calyx’s Medical Imaging team leverages our established operational footprint to implement an imaging strategy that acquires complex yet optimized CNS images from investigative sites around the world.
With local support in India, China, North America, and Europe, you can have confidence that the imaging components of your CNS trial will run smoothly and deliver high quality data you can rely on. Every time.
Discover Our Therapeutic Expertise
Calyx’s expertise spans across all phases of clinical development and therapeutic areas. In addition to CNS, we have significant experience and proven capabilities in providing medical imaging services to support the clinical development of new treatments in oncology, musculoskeletal, and many other therapeutic areas.